Nanoparticles as potential risk during femtosecond laser ablation
Source abstract
Abstract
During femtosecond (fs) laser ablation, fumes with remarkably low emission mass rates compared to conventional laser processes are generated. In this case the size of particles released in the workplace is relatively small, in the range of 10 nm–1 μm. The high amount of inhalable particles generated during femtosecond laser ablation has to be considered as a potential health risk, demanding quantification. In order to provide safety-related statements on nonbeam hazards during laser materials processing, the particle size distribution during femtosecond laser ablation is studied. Possible effects on this distribution like the laser parameters, materials, and the process atmosphere are examined. The mass flow rate and aerodynamic particle size distribution during femtosecond laser ablation were studied for metals (Ti, Co, Ag, Au, Mg), ceramic (ZrO2), and organic (polycarbonate, paper, graphite) materials. In addition, the influence of laser and process parameters (fluence, pulse overlap, gas atmosphere) on the particle size distribution has been investigated. At typical laser parameters (50 μJ, 1 kHz, 150 fs) used for microstructuring, the emission mass rates for nine different target materials are in the range of 5–120 mg h−1, and the share of nanoparticles varies from 10% to 99% depending on material and laser parameters. A maximum particle generation rate, defined as number of particles generated per pulse per centimeter squared, of 108 cm−2 has been observed, which is 100 times higher compared to Nd:yttrium-aluminum-garnet laser ablation. The nanoparticle number concentration in the ablation chamber is in the range of 104–106 per cm3, the generation rate amounts to 108 particles per second. The particle surface area of biopersistent particles has been calculated in a worst-case scenario and compared to nanoparticle toxicity indicators from literature. The amount of the fs-laser generated particle surface area (<1 cm2 per day) is negligible compared to the thresholds of an inflammatory response in the animal model (200 cm2 of total nanoparticle surface per cm2 lung surface area). But within one laser manufacturing shift, the generated nanoparticles may accumulate in the workplace to a number concentration which is 200 times higher than the background concentration. We have used laser parameters which are commonly reported in literature. For the risks assessment during high-productivity processes, it has to be considered that femtosecond lasers available today deliver beams with an average output power of 5–50 times higher than that applied in this investigation. There is no standard or regulation effective today with definitions based on the size of particulate process by-products, so that the design of a laser ablation system is not restricted by the share of nanoparticles released by this machinery. The calculation of the nominal hygienic air requirement limit values and the nominal air volume flow rate shows that the process is safe with regards to nonbeam hazards for any of the studied materials if air exchange rates higher than 3 h−1 are applied (e.g., 150 m3/h for a typical 50 m3 lab). Despite the potential risk of the generated nanoparticles, the described method may also be quite useful for the production of well-defined nanoparticulate reference materials for toxicology studies in the future.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Laser-induced spectroscopy and plasma · Ocular and Laser Science Research · Air Quality and Health Impacts
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laser Zentrum Hannover e.V., Hollerithallee 8, 30419 Hannover, Germany
References (24)
Show source-provided references
1. 2005 · 105
2. Dausinger · 2004 · 309
3. J. Aerosol Sci. · 2004 · 35 · 151310.1016/j.jaerosci.2004.07.003 ↗
4. 2001 · 716
5. 375
6. Toxicological hazards of inhaled nanoparticles-Potential implication for drug delivery10.1166/jnn.2004.081 ↗
7. Particulate air pollution and risk of ST-segment depression during repeated submaxial exercise tests among subjects with coronary heart disease-The exposure and risk Assessment for fine and ultrafine particles in ambient air (ULTRA) study10.1161/01.CIR.0000027561.41736.3C ↗
8. Ultrafine particles in urban air and respiratory health among adult asthmatics10.1183/09031936.01.17304280 ↗
9. Translation of inhaled ultrafine particles to the brain
10. Nanoparticle technology for delivery of drugs across the blood-Brain barrier10.1021/js980084y ↗
11. Dickmann · 2003
12. 2005 · 81
13. Correlation between particle size, in vivo particle persistence, and lung injury
14. In vitro determinants of particulate toxicity: The dosemetric for poorly soluble dusts
15. 2000 · 79
16. 1999
17. Gas and pressure dependence for the mean size of nanoparticles produced by laser ablation of flowing aerosols10.1023/A:1010014004508 ↗
18. Variation of particle number and mass concentration in various size ranges of ambient aerosols in Eastern Germany10.1016/S1352-2310(97)00260-4 ↗
19. Performance of a mobile aerosol spectrometer for an in situ characterization of environmental aerosols in Frankfurt City10.1016/0960-1686(92)90375-U ↗
20. Pulmonary effects of inhaled ultrafine particles
21. In vitro determinants of particulate toxicity. The dose-metric for poorly soluble dusts
22. Correlation between particle size, in vivo particle persistence, and lung injury
23. Human respiratory tract model for radiological protection
24. Threshold for nanoparticles: Particle surface area defines grade of pulmonary inflammation